欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/4327/003
药品名称Sitagliptin-ratiopharm 100 mg Filmtabletten
活性成分
    • SITAGLIPTIN malate 132.92 mg
剂型Film-coated tablet
上市许可持有人ratiopharm GmbH Graf-Arco-Str. 3 89079 Ulm Germany
参考成员国 - 产品名称Germany (DE)
Sitagliptin-ratiopharm 100 mg Filmtabletten
互认成员国 - 产品名称
    • Denmark (DK)
    • Netherlands (NL)
    • Luxembourg (LU)
      Sitagliptin-ratiopharm, 100 mg, Comprimé pelliculé
    • Iceland (IS)
      Sitagliptin ratiopharm 100 mg Filmuhúðuð tafla
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
      Sitagliptin ratiopharm 100 mg Filmtabletten
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
    • Finland (FI)
    • Poland (PL)
    • Latvia (LV)
      Sitagliptin Teva 100 mg apvalkotās tabletes
    • Lithuania (LT)
      Sitagliptin Teva 100 mg plėvele dengtos tabletės
    • Estonia (EE)
      SITAGLIPTIN TEVA
    • Hungary (HU)
      SITAGLIPTIN TEVA 100 mg filmtabletta
    • Czechia (CZ)
      Sitagliptin Teva 100 mg
    • Slovakia (SK)
      Sitagliptin Teva 100 mg
    • Croatia (HR)
      Sitagliptin Pliva 100 mg filmom obložene tablete
许可日期2016/07/06
最近更新日期2024/01/22
药物ATC编码
    • A10BH01 sitagliptin
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase